• September 27, 2020
    • Loading stock data...
  • German cannabinoid sales climb to 15 million in March


    Health insurance cannabis sales in Germany soared in Q1 2020, reaching a new record high of almost €15 million in March, more than 50% above the €9.5m of a year before.

    The last data release by GKV, the public insurer reaching 90% of the German population, comes to confirm the ascendant trend of the German medical cannabis market, which has been doubling every year since it was legalised in 2017.

    However, the exceptionally good results in March 2020 may reflect some patients redeeming their prescriptions earlier to cope with the COVID-19 crisis, similar to the stockpiling seen in North American markets during March, before sales returned to their trend.

    Evolution in Q2 will bring a more complete picture of the coronavirus effects over medicinal cannabis sales, despite the main distributors stating that no supply breakdowns had occurred before June 2020, when exports by the Dutch supplier Bedrocan were halted.

    Read full article here: https://prohibitionpartners.com/2020/06/23/german-cannabinoid-sales-climb-to-e15-million-in-march/


    About Author

    Comments are closed.